Dyne was founded with a singular focus: to deliver life-transforming therapies for people living with serious muscle diseases. We are utilizing our proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery and advance modern oligonucleotide therapeutic candidates. We have assembled an exceptional team with deep experience in muscle disease, rare disorders, drug development and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in the fields of muscle disease drug discovery and development and nucleic acid therapeutics, who share our mission.
Because together, we are stronger.
Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities:
President and Chief Executive Officer
Chief Operating Officer
Chief Medical Officer
Chief Scientific Officer
Senior Vice President, Global Head of Medical Affairs
Senior Vice President, Business Development
Senior Vice President, Head of Regulatory Affairs
Senior Vice President, Chemistry, Manufacturing and Controls
Senior Vice President, Head of Finance & Administration
Senior Vice President, Head of Corporate Communications & Investor Relations
Vice President, Head of Preclinical Development
Senior Vice President, Pharmacovigilance
Vice President, Finance
VP, Global Head of Patient Advocacy and Engagement
Vice President, Head of Intellectual Property
Vice President, Head of Human Resources
Senior Scientific Advisor
For general inquiries, email us at firstname.lastname@example.org.
To learn more about partnerships or working together, email us at email@example.com.
For investor and media inquiries, email us at firstname.lastname@example.org
1560 Trapelo Road
Waltham, MA 02451